| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.59B | 23.79B | 22.21B | 19.57B | 20.00B | 16.01B |
| Gross Profit | 10.15B | 10.83B | 9.97B | 9.18B | 8.45B | 6.84B |
| EBITDA | 3.29B | 3.75B | 3.22B | 2.70B | 2.31B | 657.80M |
| Net Income | 1.87B | 2.32B | 1.96B | 1.55B | 1.21B | 958.45M |
Balance Sheet | ||||||
| Total Assets | 13.08B | 15.55B | 14.24B | 14.75B | 12.94B | 11.46B |
| Cash, Cash Equivalents and Short-Term Investments | 6.31B | 7.88B | 6.71B | 7.51B | 4.99B | 3.16B |
| Total Debt | 2.74B | 2.89B | 3.11B | 4.15B | 3.14B | 3.53B |
| Total Liabilities | 6.01B | 7.06B | 6.59B | 7.93B | 7.25B | 7.23B |
| Stockholders Equity | 7.00B | 8.40B | 7.60B | 6.79B | 5.69B | 4.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.82B | 1.37B | 2.09B | 987.77M | -829.02M |
| Operating Cash Flow | 0.00 | 3.13B | 1.74B | 2.53B | 1.67B | -94.53M |
| Investing Cash Flow | 0.00 | -229.33M | -439.28M | -465.00M | -12.77M | -406.05M |
| Financing Cash Flow | 0.00 | -1.76B | -2.09B | 413.77M | 135.24M | 276.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥26.82B | 15.58 | ― | 0.73% | 17.32% | 33.18% | |
80 Outperform | ¥29.69B | 12.03 | ― | 4.36% | 7.11% | 20.03% | |
75 Outperform | ¥27.21B | 10.83 | ― | 1.21% | 5.85% | 5.71% | |
74 Outperform | ¥26.48B | 11.87 | ― | 2.45% | 8.50% | 2.04% | |
71 Outperform | ¥20.68B | 11.91 | ― | 1.70% | 15.21% | 12.50% | |
65 Neutral | ¥30.26B | 8.57 | 10.34% | 4.82% | -2.76% | 36.33% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |